In another study, a combination of synthetic GIP, synthetic GLP-1 (7-36) amide, and synthetic human glucagon-like peptide-2 (GLP-2) infused into ten subjects with diabetes, during an IV glucose infusion matching an OGTT, glucagon, and insulin secretion were measured. This evidence concerns the gene GIP and diabetes mellitus.